Innovations in sequencing technologies over the past decade have been critical driving forces behind the ongoing revolution in medicine and the life sciences. The Nanopore sequencing platform (Oxford Nanopore Technologies) is a newer, so-called third generation sequencing technology with several futuristic features, including a tremendously long-read length capacity, real-time data output, and pocket-size mobility (thanks to the MinION sequencer). A critical barrier to broader applications of this emerging technology has been its disappointingly high sequencing error rates. The overall goal of this study is to develop a novel barcoding technology with which to radically improve the accuracy of single-molecule, target DNA sequencing for the Nanopore sequencing platform. Long-range, high-accuracy sequencing will be essential in delineating the heterogeneity of cellular or viral populations in diseases such as cancer or viral infection. In this proposal, we will focus on the genotyping of HIV-1 as a proof of principle. HIV-1 is an excellent model system because of its relatively small genome (approximately 9 Kbp), the high degree of intra-patient genetic diversity, and the availability of sufficient NGS and Sanger sequence data for the purpose of comparison. We will develop and establish standard experimental procedures for generating a new-generation barcode library and for using this library to perform sequencing error correction processes (Aims 1 and 2); We will then test the utility of our method using laboratory strains of HIV-1 (Aims 3).

Public Health Relevance

Long-range, high-accuracy sequencing will be essential in delineating the heterogeneity of cellular or viral populations in diseases such as cancer or viral infection. In this proposal, we will develop a novel sequencing platform technology for high-accuracy, long-range single DNA sequencing, which has the potential to provide an unprecedented means of resolving key issues in broad areas of science and medicine. As a proof of principal, we will focus on sequencing the HIV-1 genome for the accurate and ultrasensitive detection of viral variants.

Agency
National Institute of Health (NIH)
Institute
National Human Genome Research Institute (NHGRI)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21HG010108-01
Application #
9551813
Study Section
Special Emphasis Panel (ZHG1)
Program Officer
Smith, Michael
Project Start
2018-08-01
Project End
2021-05-31
Budget Start
2018-08-01
Budget End
2019-05-31
Support Year
1
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Ohio State University
Department
Veterinary Sciences
Type
Schools of Veterinary Medicine
DUNS #
832127323
City
Columbus
State
OH
Country
United States
Zip Code
43210